These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 35409325)

  • 1. In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors.
    Saeed MEM; Yücer R; Dawood M; Hegazy MF; Drif A; Ooko E; Kadioglu O; Seo EJ; Kamounah FS; Titinchi SJ; Bachmeier B; Efferth T
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring inhibitory potential of Curcumin against various cancer targets by in silico virtual screening.
    Mahajanakatti AB; Murthy G; Sharma N; Skariyachan S
    Interdiscip Sci; 2014 Mar; 6(1):13-24. PubMed ID: 24464700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Phytocompounds from Common Indian Spices for Identification of Three Potential Inhibitors of Breast Cancer: A Molecular Modelling Approach.
    Hazra S; Ray AS; Rahaman CH
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells.
    Jin R; Xia Y; Chen Q; Li W; Chen D; Ye H; Zhao C; Du X; Shi D; Wu J; Liang G
    Drug Des Devel Ther; 2016; 10():979-95. PubMed ID: 27042000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Therapeutic Potential of Curcumin and Synthetic Derivatives: A Computational Approach to Anti-Obesity Treatments.
    Moetlediwa MT; Jack BU; Mazibuko-Mbeje SE; Pheiffer C; Titinchi SJJ; Salifu EY; Ramharack P
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational investigation of
    Yousaf MA; Anwer SA; Basheera S; Sivanandan S
    J Biomol Struct Dyn; 2024; 42(4):1901-1923. PubMed ID: 37154824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
    Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity and Anti-inflammatory Activity of Flavonoid Derivatives Targeting NF-kappaB.
    Naik KK; Thangavel S; Alam A
    Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):119-132. PubMed ID: 27842477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents.
    Afzal O; Yusuf M; Ahsan MJ; Altamimi ASA; Bakht MA; Ali A; Salahuddin
    Plants (Basel); 2022 Oct; 11(20):. PubMed ID: 36297760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of
    Ejaz SA; Aziz M; Fawzy Ramadan M; Fayyaz A; Bilal MS
    Molecules; 2023 May; 28(10):. PubMed ID: 37241785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer.
    Purawarga Matada GS; Dhiwar PS; Abbas N; Singh E; Ghara A; Das A; Bhargava SV
    J Biomol Struct Dyn; 2022 Aug; 40(13):6183-6192. PubMed ID: 33525984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin in combined cancer therapy.
    Troselj KG; Kujundzic RN
    Curr Pharm Des; 2014; 20(42):6682-96. PubMed ID: 25341940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of EGFR inhibitors as potential agents for cancer therapy: pharmacophore-based modeling, molecular docking, and molecular dynamics investigations.
    Ashiru MA; Ogunyemi SO; Temionu OR; Ajibare AC; Cicero-Mfon NC; Ihekuna OA; Jagun MO; Abdulmumin L; Adisa QK; Asibor YE; Okorie CJ; Lawal MO; Babalola MO; Abdulrasaq IT; Salau LB; Olatunji IO; Bankole MA; Daud AB; Adeyemi AO
    J Mol Model; 2023 Apr; 29(5):128. PubMed ID: 37016200
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Liang Y; Zhao J; Zou H; Zhang J; Zhang T
    Food Funct; 2021 Nov; 12(21):10667-10675. PubMed ID: 34604873
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Chowrasia D; Jafri A; Azad I; Rais J; Sharma N; Khan F; Kumar A; Kumar S; Arshad M
    J Biomol Struct Dyn; 2022 Nov; 40(18):8569-8586. PubMed ID: 33955334
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Feng L; Lu WH; Li QY; Zhang HY; Xu LR; Zang WQ; Guo WT; Li YF; Zheng WJ; Geng YX; Li Q; Liu YH
    Am J Chin Med; 2023; 51(5):1189-1209. PubMed ID: 37314412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining empirical knowledge, in silico molecular docking and ADMET profiling to identify therapeutic phytochemicals from Brucea antidysentrica for acute myeloid leukemia.
    Bultum LE; Tolossa GB; Lee D
    PLoS One; 2022; 17(7):e0270050. PubMed ID: 35895695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis,
    Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J
    J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HER2 inhibitors from curcumin derivatives using combination of
    Saibu OA; Singh G; Olugbodi SA; Oluwafemi AT; Ajayi TM; Hammed SO; Oladipo OO; Odunitan TT; Omoboyowa DA
    J Biomol Struct Dyn; 2023; 41(21):12328-12337. PubMed ID: 36752338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells.
    Coker-Gurkan A; Bulut D; Genc R; Arisan ED; Obakan-Yerlikaya P; Palavan-Unsal N
    Mol Biol Rep; 2019 Feb; 46(1):355-369. PubMed ID: 30467667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.